EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

A Novel Ocular Fibrosis Signature for AMD Using the Two-Stage Laser-Induced Subretinal Fibrosis Mouse Model

David Hughes, Axelle E M Larue, Petr Taus, Elke Markert, Diya Bhattacharyya, Yaser Atlasi, Heike Neubauer, Heping Xu, Mei Chen

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.10.49 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by David Hughes and 8 co-authors. Institution: The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom. Major MEDLINE topics: Retinal Pigment Epithelium, Macular Degeneration. 68 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Subretinal fibrosis is a major cause of irreversible vision loss in neovascular age-related macular degeneration (AMD), yet no effective antifibrotic therapies exist due to poorly defined molecular drivers. This study aimed to derive and validate a persistent ocular fibrosis signature using the two-stage laser-induced subretinal fibrosis mouse model and to assess its translational relevance in human AMD.

Methods

RNA sequencing (RNA-seq) was performed on retinal pigment epithelium (RPE)/choroid tissues collected at days 3, 6, and 10 following the second laser injury in the two-stage model. A novel core fibrosis signature of 88 persistently upregulated genes was observed across all time points and cross-validated in an independent mouse dataset (GSE189555) and multiple human AMD RNA-seq datasets (GSE115828, GSE146887, GSE135092), including surgically extracted choroidal neovascularization (CNV) membranes and macular RPE/choroid samples. Key signature genes were further validated by immunofluorescence in human subretinal fibrotic and age-matched tissues.

Results

The novel ocular fibrosis signature was enriched in epithelial-mesenchymal transition, complement activation, and inflammatory pathways and showed choroid-specific expression with minimal retinal involvement. Cross-validation on independent chronic mouse data and multiple human AMD datasets (peripheral retina, surgically extracted CNV membranes, and macular RPE/choroid) confirmed a progressive enrichment in advanced disease stages. Immunofluorescence in human fibrotic tissue validated key genes (tenascin C, tissue inhibitor of metalloproteinases 1, and apelin receptor) and showed colocalization with myofibroblast-like cells and microglia.

Conclusions

We identified a novel, persistent, choroid-specific ocular fibrosis signature with strong cross-species conservation, highlighting fibrogenic-associated drivers and providing a valuable translational tool to understand subretinal fibrosis development and targeted antifibrotic therapies in neovascular AMD.

Subjects

MeSH terms (MEDLINE)

Retinal Pigment EpitheliumMacular DegenerationAnimalsMiceFibrosisDisease Models, AnimalHumansMice, Inbred C57BLChoroidal NeovascularizationChoroidMale

Authors and institutions

  • The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
  • Johnston Cancer Research Centre, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
  • Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach Riss, Germany.

Cite

APA

Hughes, D., Larue, A. E. M., Taus, P., Markert, E., Bhattacharyya, D., Atlasi, Y., Neubauer, H., Xu, H., & Chen, M. (2026). A Novel Ocular Fibrosis Signature for AMD Using the Two-Stage Laser-Induced Subretinal Fibrosis Mouse Model. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.10.49

Vancouver

Hughes D, Larue AEM, Taus P, Markert E, Bhattacharyya D, Atlasi Y, et al. A Novel Ocular Fibrosis Signature for AMD Using the Two-Stage Laser-Induced Subretinal Fibrosis Mouse Model. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.10.49

BibTeX
@article{Hughes2026,
  author = {Hughes, David and Larue, Axelle E M and Taus, Petr and Markert, Elke and Bhattacharyya, Diya and Atlasi, Yaser and Neubauer, Heike and Xu, Heping and Chen, Mei},
  title = {A Novel Ocular Fibrosis Signature for AMD Using the Two-Stage Laser-Induced Subretinal Fibrosis Mouse Model},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.10.49}
}
Start for free →